Diabetes Research and Clinical Practice
Volume 56, Issue 3 , Pages 159-171 , June 2002

Troglitazone improves GLUT4 expression in adipose tissue in an animal model of obese type 2 diabetes mellitus

  • Masahiko Furuta

      Affiliations

    • Third Department of Internal Medicine, Mie University School of Medicine, Edobashi 2-174, Tsu, Mie 514-8507, Japan
    • ,
  • Yutaka Yano

      Affiliations

    • Third Department of Internal Medicine, Mie University School of Medicine, Edobashi 2-174, Tsu, Mie 514-8507, Japan
    • Corresponding Author InformationCorresponding author. Tel.: +81-59-232-1111; fax: +81-59-231-5223
    • ,
  • Esteban C. Gabazza

      Affiliations

    • Third Department of Internal Medicine, Mie University School of Medicine, Edobashi 2-174, Tsu, Mie 514-8507, Japan
    • ,
  • Rika Araki-Sasaki

      Affiliations

    • Third Department of Internal Medicine, Mie University School of Medicine, Edobashi 2-174, Tsu, Mie 514-8507, Japan
    • ,
  • Takashi Tanaka

      Affiliations

    • Third Department of Internal Medicine, Mie University School of Medicine, Edobashi 2-174, Tsu, Mie 514-8507, Japan
    • ,
  • Akira Katsuki

      Affiliations

    • Third Department of Internal Medicine, Mie University School of Medicine, Edobashi 2-174, Tsu, Mie 514-8507, Japan
    • ,
  • Yasuko Hori

      Affiliations

    • Third Department of Internal Medicine, Mie University School of Medicine, Edobashi 2-174, Tsu, Mie 514-8507, Japan
    • ,
  • Kaname Nakatani

      Affiliations

    • Department of Laboratory Medicine, Mie University School of Medicine, Mie, Japan
    • ,
  • Yasuhiro Sumida

      Affiliations

    • Third Department of Internal Medicine, Mie University School of Medicine, Edobashi 2-174, Tsu, Mie 514-8507, Japan
    • ,
  • Yukihiko Adachi

      Affiliations

    • Third Department of Internal Medicine, Mie University School of Medicine, Edobashi 2-174, Tsu, Mie 514-8507, Japan

Received 17 July 2001 ,Revised 19 November 2001 ,Accepted 6 December 2001.

References 

  1. DeFronzo RA, Ferrannini E, Koivisto V. New concepts in the pathogenesis and treatment of noninsulin-dependent diabetes mellitus. Am. J. Med. 1983;74(Suppl. 1A):52–81
  2. Olefsky JM. Pathogenesis of insulin resistance and hyperglycemia in non-insulin-dependent diabetes mellitus. Am. J. Med. 1985;79(Suppl. 3B):1–7
  3. Suter SL, Nolan JJ, Wallace P, Gumbiner B, Olefsky JM. Metabolic effects of new oral hypoglycemic agent CS-045 in NIDDM subjects. Diabetes Care. 1992;15:193–203
  4. Kumar S, Boulton AJM, Beck-Nielsen H, et al.  Troglitazone, an insulin action enhancer, improves metabolic control in NIDDM patients. Diabetologia. 1996;39:701–709
  5. Fujiwara T, Yoshioka S, Yoshioka T, Ushiyama I, Horikoshi H. Characterization of new oral antidiabetic agent CS-045: studies in KK and ob/ob mice and Zucker fatty rats. Diabetes. 1988;37:1549–1558
  6. Lehmann JM, Moore LB, Smith-Oliver TA, Wilkison WO, Willson TM, Kliewer SA. An antidiabetic thiazolidinedione is a high affinity ligand for peroxisome proliferator-activated receptorγ (PPARγ). J. Biol. Chem. 1995;270:12953–12956
  7. Kawano K, Hirashima T, Mori S, Saitoh Y, Kurosumi M, Natori T. Spontaneous long-term hyperglycemic rat with diabetic complications: Otsuka Long–Evans Tokushima Fatty (OLETF) strain. Diabetes. 1992;41:1422–1428
  8. Kawano K, Hirashima T, Mori S, Natori T. OLETF (Otsuka Long–Evans Tokushima Fatty) rat: a new NIDDM rat strain. Diabetes Res. Clin. Prac. Suppl. 1994;24:S317–320
  9. Ishikawa M, Koga K. Measurement of abdominal fat by magnetic resonance imaging of OLETF rats, an animal model of NIDDM. Magn. Reson. Imaging. 1998;16:45–53
  10. Okauchi N, Mizuno A, Yoshimoto S, Zhu M, Sano T, Shima K. Is caloric restriction effective in preventing diabetes mellitus in the Otsuka Long–Evans Tokushima Fatty rat, a model of spontaneous non-insulin-dependent diabetes mellitus?. Diabetes Res. Clin. Prac. 1995;27:97–106
  11. Shima K, Shi K, Mizuno A, Sano T, Ishida K, Noma Y. Exercise training has a long-lasting effect on prevention of non-insulin-dependent diabetes mellitus in Otsuka–Long–Evans–Tokushima Fatty rats. Metabolism. 1996;45:475–480
  12. Mueckler M. Family of glucose-transporter genes: implications for glucose homeostasis and diabetes. Diabetes. 1990;39:6–11
  13. Fukumoto H, Kayano T, Buse JB, et al.  Cloning and characterization of the major insulin-responsive glucose transporter expressed in human skeletal muscle and other insulin-responsive tissues. J. Biol. Chem. 1989;264:7776–7779
  14. Klip A, Ramlal T, Young DA, Holloszy JO. Insulin-induced translocation of glucose transporters in rat hindlimb muscles. FEBS Lett. 1987;224:224–230
  15. Cushman SW, Wardzala LJ. Potential mechanism of insulin action on glucose transport in the isolated rat adipose cell: apparent translocation of intracellular transport systems to the plasma membrane. J. Biol. Chem. 1980;255:4758–4762
  16. Moller DE, Flier JS. Insulin resistance-mechanisms, syndromes, and implications. New Engl. J. Med. 1991;325:938–948
  17. DeFronzo RA, Bonadonna RC, Ferrannini E. Pathogenesis of NIDDM: a balanced overview. Diabetes Care. 1992;15:318–353
  18. Ohsumi J, Sakakibara S, Yamaguchi J, et al.  Troglitazone prevents the inhibitory effects of inflammatory cytokines on insulin-induced adipocyte differentiation in 3T3-L1 cells. Endocrinology. 1994;135:2279–2282
  19. Goto Y, Sumida Y, Flanagan JE, et al.  Effects of fluorescein isothiocyanate on insulin actions in rat adipocytes. Arch. Biochem. Biophys. 1992;293:224–230
  20. Oka Y, Asano T, Shibasaki Y, Kasuga M, Kanazawa Y, Takaku F. Studies with antipeptide antibody suggest the presence of at least two types of glucose transporter in rat brain and adipocyte. J. Biol. Chem. 1988;263:13432–13439
  21. Rodbell M. Metabolism of isolated fat cells: effects of hormones on glucose metabolism and lipolysis. J. Biol. Chem. 1964;239:375–380
  22. Kono T, Barham FW. The relationship between the insulin-binding capacity of fat cells and the cellular response to insulin: studies with intact and trypsin-treated fat cells. J. Biol. Chem. 1971;246:6210–6216
  23. Ishizuka T, Kajita K, Miura A, et al.  DHEA improves glucose uptake via activations of protein kinase C and phosphatidylinositol 3-kinase. Am. J. Physiol. 1999;276:E196–E204
  24. Kono T. Glucose transport activity and its insulin-dependent redistribution in adipocytes: assessment by fractionation and reconstitution. In:  Larner J,  Pohl SL editor. Methods in Diabetes Research. 1, Part A:New York, NY: Wiley-Interscience; 1984;p. 101–112
  25. Avruch J, Wallach DFH. Preparation and properties of plasma membrane and endoplasmic reticulum fragments from isolated rat fat cells. Biochim. Biophys. Acta. 1971;233:334–347
  26. Simpson IA, Yver DR, Hissin PJ, et al.  Insulin-stimulated translocation of glucose transporters in the isolated rat adipose cells: characterization of subcellular fractions. Biochim. Biophys. Acta. 1983;763:393–407
  27. Bradford MM. A rapid and sensitive method for the quantitation of microgram quantities of protein utilizing the principle of protein–dye binding. Anal. Biochem. 1976;72:248–254
  28. Laemmli UK. Cleavage of structural proteins during the assembly of the head of bacteriophage T4. Nature. 1970;227:680–685
  29. Towbin H, Staehelin T, Gordon J. Electrophoretic transfer of proteins from polyacrylamide gels to nitrocellulose sheets: procedure and some applications. Proc. Natl. Acad. Sci. USA. 1979;76:4350–4354
  30. Nivet V, Hajduch E, Hainault I, Delattre J, Lavau M, Hainque B. Sensitive northern blot hybridization using digoxigenin RNA probes for the mRNA detection of two glucose transporter isoforms. Cell. Mol. Biol. 1995;41:979–984
  31. Chomczynski P, Sacchi N. Single-step method of RNA isolation by acid guanidinium thiocyanate–phenol–chloroform extraction. Anal. Biochem. 1987;162:156–159
  32. Baron AD, Laakso M, Brechtel G, Edelman SV. Reduced capacity and affinity of skeletal muscle for insulin-mediated glucose uptake in noninsulin dependent diabetic subjects. J. Clin. Invest. 1991;87:1186–1194
  33. Pedersen O, Bak JF, Andersen PH, et al.  Evidence against altered expression of GLUT1 or GLUT4 in skeletal muscle of patients with obesity or NIDDM. Diabetes. 1990;39:865–870
  34. Eriksson J, Koranyi L, Bourey R, et al.  Insulin resistance in type 2 (non-insulin-dependent) diabetic patients and their relatives is not associated with a defect in the expression of the insulin-responsive glucose transporter (GLUT-4) gene in human skeletal muscle. Diabetologia. 1992;35:143–147
  35. Park KS, Ciaraldi TP, Abrams-Carter L, Mudaliar S, Nikoulina SE, Henry RR. Troglitazone regulation of glucose metabolism in human skeletal muscle cultures from obese type II diabetic subjects. J. Clin. Endocrinol. Metab. 1998;83:1636–1643
  36. Sinha MK, Raineri-Maldonado C, Buchanan C, et al.  Adipose tissue glucose transporters in NIDDM: decreased levels of muscle/fat isoform. Diabetes. 1991;40:472–477
  37. Kahn BB, Charron MJ, Lodish HF, Cushman SW, Flier JS. Differential regulation of two glucose transporters in adipose cells from diabetic and insulin-treated diabetic rats. J. Clin. Invest. 1989;84:404–411
  38. Hofmann C, Lorenz K, Colca JR. Glucose transport deficiency in diabetic animals is corrected by treatment with the oral antihyperglycemic agent pioglitazone. Endocrinology. 1991;129:1915–1925
  39. Young PW, Cawthorne MA, Coyle PJ, et al.  Repeat treatment of obese mice with BRL 49653, a new and potent insulin sensitizer, enhances insulin action in white adipocytes: association with increased insulin binding and cell-surface GLUT4 as measured by photoaffinity labeling. Diabetes. 1995;44:1087–1092
  40. Barroso I, Gurnell M, Crowley VEF, et al.  Dominant negative mutations in human PPARγ associated with severe insulin resistance, diabetes mellitus and hypertension. Nature. 1999;402:880–883
  41. Wu Z, Xie Y, Morrison RF, Bucher NLR, Farmer SR. PPARγ induces the insulin-dependent glucose transporter GLUT4 in the absence of C/EBPα during the conversion of 3T3 fibroblasts into adipocytes. J. Clin. Invest. 1998;101:22–32
  42. Rieusset J, Auwerx J, Vidal H. Regulation of gene expression by activation of the peroxisome proliferator-activated receptorγ with rosiglitazone (BRL 49653) in human adipocytes. Biochem. Biophys. Res. Commun. 1999;265:265–271
  43. Fajas L, Auboeuf D, Raspé E, et al.  The organization, promoter analysis, and expression of the human PPARγ gene. J. Biol. Chem. 1997;272:18779–18789
  44. Braissant O, Foufelle F, Scotto C, Dauça M, Wahli W. Differential expression of peroxisome proliferator-activated receptors (PPARs): tissue distribution of PPAR-α, -β, and -γ in the adult rat. Endocrinology. 1996;137:354–366
  45. Shimaya A, Noshiro O, Hirayama R, Yoneta T, Niigata K, Shikama H. Insulin sensitizer YM268 ameliorates insulin resistance by normalizing the decreased content of GLUT4 in adipose tissue of obese Zucker rats. Eur. J. Endocrinol. 1997;137:693–700
  46. Yonemitsu S, Nishimura H, Shintani M, et al.  Troglitazone induces GLUT4 translocation in L6 myotubes. Diabetes. 2001;50:1093–1101
  47. Park KS, Ciaraldi TP, Lindgren K, et al.  Troglitazone effects on gene expression in human skeletal muscle of type II diabetes involve upregulation of peroxisome proliferator-activated receptor-γ. J. Clin. Endocrinol. Metab. 1998;83:2830–2835
  48. Spiegelman BM. PPAR-γ: adipogenic regulator and thiazolidinedione receptor. Diabetes. 1998;47:507–514
  49. Spiegelman BM, Flier JS. Adipogenesis and obesity: rounding out the big picture. Cell. 1996;87:377–389
  50. Hotamisligil GS, Shargill NS, Spiegelman BM. Adipose expression of tumor necrosis factor-α: direct role in obesity-linked insulin resistance. Science. 1993;259:87–91
  51. Peraldi P, Spiegelman BM. TNF-α and insulin resistance: summary and future prospects. Mol. Cell. Biochem. 1998;182:169–175
  52. Kwon G, Xu G, Marshall CA, McDaniel ML. Tumor necrosis factorα- induced pancreaticβ-cell insulin resistance is mediated by nitric oxide and prevented by 15-deoxy-Δ12,14-prostaglandin J2 and aminoguanidine. J. Biol. Chem. 1999;274:18702–18708
  53. Okuno A, Tamemoto H, Tobe K, et al.  Troglitazone increases the number of small adipocytes without the change of white adipose tissue mass in obese Zucker rats. J. Clin. Invest. 1998;101:1354–1361

PII: S0168-8227(01)00373-4

Diabetes Research and Clinical Practice
Volume 56, Issue 3 , Pages 159-171 , June 2002

Article Tools

* Image Usage & Resolution